Pharmaceutical gelatin market size is worth USD 1.59 billion

New York, U.S., Sept. 01, 2022 (GLOBE NEWSWIRE) — Pharmaceutical Gelatin Market Overview

According to a comprehensive research report by Market Research Future (MRFR), “Pharmaceutical gelatin market by Source, by Function, by Application, by Type and by Region — Forecast to 2030the market is expected to cross USD 1.59 billion by 2030 at a CAGR of 6.4% during the forecast period 2022-2030.

Market scope:

Pharmaceutical gelatin is a high molecular weight, colorless, water-soluble, thermoreversible, biocompatible, transparent and sensitive substance. By partially hydrolyzing collagen, it is made from animal skin, white connective tissue and bone. Both hard capsules and soft gels are produced using gelatin as an excipient. Additionally, it is used as a blood plasma substitute, binder for tablets, and in other applications.

Get Free Sample PDF Brochure @

Report Scope:

Report attribute Details
Market size 2030 $1.59 billion
CAGR 6.4%
base year 2021
Forecast period 2022-2030
Historical data 2020
Forecast units Value (USD billion)
Report cover Revenue forecasts, competitive landscape, growth factors and trends
Segments Covered By source, function, application, type
Geographical areas covered North America, Europe, Asia-Pacific and Rest of the World (RoW)
Key Market Drivers Growing demand for pharmaceutical gelatin
Increase in the use of gelatin among nutraceutical and pharmaceutical drug manufacturers

Pharmaceutical Gelatin Market Competitive Analysis:

The main market players are:

  • Darling Ingredients Inc. (USA)
  • Nitta Gelatin Inc. (Japan)
  • Tessenderlo Group (Belgium)
  • Gelita AG (Germany)
  • Weishard International (France)
  • Trobas Gelatine BV (Netherlands)
  • Lonza Group AG (Switzerland)
  • Lapi Gelatin SpA (Italy)
  • Italgelatine SpA (Italy)
  • Xiamen Gelken Gelatin Co.Ltd. (China)
  • Gelco International (Brazil)
  • Aspire Pharmaceuticals (USA)
  • India Gelatin & Chemicals Ltd. (India)
  • Gelnex Industria E Comercio Ltda (Brazil)
  • Henan Boom Gelatin Co. Ltd (China)
  • Baotou Dongbao Bio-Tech Co. Ltd (China)
  • Norland Products Inc. (USA)
  • Geltech Co. Ltd (South Korea)
  • Geliko LLC (USA)
  • Kenney & Ross Limited (Canada)

Pharmaceutical gelatin market dynamics:

Market factors:

Due to factors such as the expansion of nutraceutical and pharmaceutical companies using gelatin to manufacture drugs, the pharmaceutical gelatin market is expected to increase significantly over the forecast period. The market is growing due to the expanding uses of pharmaceutical gelatin in the creation of hard and soft gelatin capsules, tablets, and vaccines. In addition, the projection period will see an increase in the incidence of chronic diseases, improvements in technology, cheap production costs for gelatin capsule shells, and greater consumer awareness of the benefits of eating foods rich in nutrients.

Gelatin’s special functional properties, including gelation, adhesion, coating, bonding, and film formation, make it a perfect choice for use in medical applications. Softgels, capsules and gelatin-coated tablets are easier to swallow while reducing the smell of the medicine. In addition, it protects drugs against environmental alterations such as oxygen and humidity and extends their shelf life. As a result, the pharmaceutical gelatin market is expanding owing to the increasing uses of this material in the creation of new drugs.

Market constraints:

Vegetarian capsule shells are produced in response to the growing demand for plant-based substitutes such as hydroxypropyl methylcellulose (HPMC) and modified starch. Additionally, the pharmaceutical gelatin market is limited by the global rise of veganism, which discourages the use of items made from animals.

Browse the in-depth (120 pages) Pharmaceutical Gelatin Market Research Report:

COVID-19 Analysis of Pharmaceutical Gelatin Market:

During this pandemic, the global pharmaceutical gelatin market is expected to expand significantly. With the onset of the COVID-19 pandemic, the growth of the pharmaceutical gelatin market is expected to be impacted by the increasing use of COVID-19 related drugs for treatment. During the COVID-19 pandemic, there has been an increase in demand for capsules and tablets for the treatment of COVID-19, pneumonia and other infectious disorders. Additionally, pharmaceutical gelatin is frequently used in COVID-19 vaccines to maintain the stability and potency of drug components during the distribution process. As a result, pharmaceutical gelatin requirements will increase throughout the projected time frame in order to create effective vaccines.

Quarantine and lockdown measures implemented in many places have created supply chain, transportation and logistics issues, making it difficult to obtain raw materials for gelatin. Additionally, this has led to a shortage of medicinal gelatin in some regions due to a gap between supply and demand. Therefore, the decrease in cross-border imports and exports could lead to supply chain disruptions, which would be very costly for raw material suppliers.

Buy now:

Pharmaceutical Gelatin Market Segmentation:

By origin

During the forecast period, the pork segment is expected to experience significant expansion. Due to its lower cost and easier availability, pork-based gelatin is one of the most commercially used gelatins in the world.

By function

During the research period, the Stabilizers industry is expected to grow at a significant CAGR. Purified pharmaceutical gelatin with low endotoxin levels is used as a stabilizer in vaccines. The stability of freeze-dried (freeze-dried) products is improved, the risk of adverse effects is reduced and patient safety is guaranteed.

By app

During the analysis period, the capsule category should dominate. One of the most popular and well-known materials used to make capsules is pharmaceutical gelatin. It ensures better dissolution rates of active pharmaceutical ingredients (API) and has fewer production costs and manufacturing restrictions.

By type

During the study period, the Type A category is expected to expand significantly.

Share your queries @

Pharmaceutical Gelatin Market Regional Analysis:

Due to rising incidence of chronic diseases including osteoarthritis, cancer and others along with the presence of significant key players in the region, North America will hold the highest market share of pharmaceutical gelatin in 2021. These participants engage in business growth. , strategic alliances and acquisitions.

Due to the abundance of raw resources like pork and cattle in the region, Europe holds the second largest market share. The market in the region is also expected to increase owing to the increased use of pharmaceutical gelatin in regenerative medicine due to its cell response properties and ability to transport a wide variety of biomolecules.

The fastest growing regional market is expected to be in Asia-Pacific for pharmaceutical gelatin. The need for the development of new drugs for the treatment of chronic diseases, including cancer, diabetes, osteoarthritis and cardiovascular disease, is growing. The need for pharmaceutical gelatin as an excipient for various pharmaceutical dosage forms, such as capsules, tablets, suspensions, emulsions, injections and the like, is finally increasing. The pharmaceutical gelatin market in the Asia-Pacific region is also expanding owing to an increase in research and contract manufacturing activities, as well as falling labor and capital costs for the production of pharmaceutical gelatin.

Africa, Latin America and the Middle East make up the rest of the globe. Government initiatives to improve the healthcare system and increasing R&D in the pharmaceutical and medical device industries are driving the global pharmaceutical gelatin market. In addition, expanding regional uses of pharmaceutical gelatin for protein delivery, gene delivery, pulmonary drug delivery, eye drug delivery and other purposes are driving the market for pharmaceutical gelatin for this substance.

Discover more research reports on The health industryby Market Research Future:

breast imaging market: Information by technology (ionizing and non-ionizing technology), by end user (hospitals, clinics and specialized centers) and by region (North America, Europe, Asia-Pacific and rest of the world) – Forecasts until 2027

Wound Debridement Products Market Research Report: By End Users (Specialty Care, Nursing Units, Ambulatory Centers, Multi-Specialty Clinics & Hospitals) & By Region (Europe, Asia-Pacific, Americas & Middle East & Africa) – Forecast to 2027

Stem Cell Testing Market Research Report: By-Products (Flow Cytometer), Technology (Micro-Fabrication Assisted Technology), Assay (Cell Viability and Toxicity Testing), Application (Dermatology), End User (Biotech Industries) – Forecast to 2027

About Market Research Future:

Market Research Future (MRFR) is a global market research company that prides itself on its services, offering comprehensive and accurate analysis with respect to various markets and consumers around the world. Market Research Future has the distinct objective of providing clients with top quality research and granular research. Our market research by products, services, technologies, applications, end users and market players for global, regional and country market segments enables our clients to see more, know more and do more , which helps answer your most important questions. questions.

Follow us: LinkedIn | Twitter